scispace - formally typeset
A

Andreas L. Birkenfeld

Researcher at King's College London

Publications -  203
Citations -  8539

Andreas L. Birkenfeld is an academic researcher from King's College London. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 36, co-authored 113 publications receiving 6362 citations. Previous affiliations of Andreas L. Birkenfeld include Max Delbrück Center for Molecular Medicine & University of Cambridge.

Papers
More filters
Journal ArticleDOI

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, +798 more
- 27 Oct 2018 - 
TL;DR: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events, and evidence-based glucagon-like peptide 1 receptor agonists should be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events.
Journal ArticleDOI

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.

TL;DR: This review will discuss recent studies in both humans and animal models of NAFLD that have implicated increases in hepatic diacylglycerol content leading to activation of novel protein kinase Cϵ (PKCϵ) resulting in decreased insulin signaling in the pathogenesis ofNAFLD‐associated hepatic insulin resistance and type 2 diabetes.
Journal ArticleDOI

Obesity and impaired metabolic health in patients with COVID-19.

TL;DR: Preliminary data suggest that people with obesity are at increased risk of severe COVID-19, but as data on metabolic parameters in patients with CO VID-19 are scarce, increased reporting is needed to improve understanding of the drug and the care of affected patients.